3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow LISPRO: new trials by email Literature Review of LISPRO trials Research Report on LISPRO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy Viaject 7, LISPRO - Type 1 Diabetes Mellitus | Phase 3 | Completed | Biodel | 20 | 2010-02-01 | 2015-08-03 |
| Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus Insulin Glulisine, Lispro, Insulin Glargine - Diabetes Mellitus | Phase 3 | Completed | Sanofi | 485 | 2007-01-01 | 2009-09-15 |
| Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents Lantus (insulin glargine [rDNA origin] injection), Humulin N, Humulin L - Diabetes Mellitus | Phase 3 | Completed | Sanofi | 250 | 2002-11-01 | 2011-01-11 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (1)
United States (2) · China (1)
Doug Green (1) · Jing Fu (1)